Sam Altman's Anti-Ageing Bet: How AI And Biology Are Beginning To Converge

Sam Altman's Anti-Ageing Bet: How AI And Biology Are Beginning To Converge

Rapamycin News
Rapamycin NewsMay 23, 2026

Summary

Ah, my mistake. They were killing it with that project, so I totally thought they made their money off it first before switching gears. Their research on plasmapheresis was actually outstanding back then, so it’s a real shame they couldn’t successfully monetize it.

Sam Altman's Anti-Ageing Bet: How AI And Biology Are Beginning To Converge

Comments

Want to join the conversation?